Biosimilar Hormones Global Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067468
  • December 2021
  • Pharmaceuticals
  • 125 Pages
Download Sample
Report Description

This report is a comprehensive study that examines the Biosimilar Hormones Global industry in depth. With reference to key regions and major nations, the study specifies the product type of Biosimilar Hormones Global as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Biosimilar Hormones Global market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Biosimilar Hormones Global market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Biosimilar Hormones Global market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Biosimilar Hormones Global Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Biosimilar Hormones Global market study. The market dynamics and factors such as the threat of a Biosimilar Hormones Global substitute, the threat of new entrants into the Biosimilar Hormones Global market, buyer bargaining power, supplier bargaining power to Biosimilar Hormones Global providing companies, and internal rivalry among Biosimilar Hormones Global providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Biosimilar Hormones Global market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Biosimilar Hormones Global industry.
 
Biosimilar Hormones Global Market Key Trends Analysis

The important factors influencing the growth of the Biosimilar Hormones Global market have been examined in this report. The driving factors that are boosting demand for Biosimilar Hormones Globals and the restraining factors that are slowing growth of the Biosimilar Hormones Global industry are addressed in depth, as well as their implications for the worldwide Biosimilar Hormones Global market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Biosimilar Hormones Global Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Biosimilar Hormones Global industry. On the basis of current and future trends, all segments of the Biosimilar Hormones Global industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Biosimilar Hormones Global Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Biosimilar Hormones Global market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Biosimilar Hormones Global market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Biosimilar Hormones Global market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Biosimilar Hormones Global market. All important stakeholders in the Biosimilar Hormones Global value chain and technological ecosystem are expected to benefit from the insights offered in the Biosimilar Hormones Global market research study.

In order to provide a broader understanding of the top competitors in the Biosimilar Hormones Global market, the research includes a company market share analysis. Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals, GC Pharma are among the major participants in the global Biosimilar Hormones Global industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals, GC Pharma
 
Major Highlights of the Biosimilar Hormones Global Market report study:
  • An in-depth examination of the global Biosimilar Hormones Global industry will be published soon.
  • The study examines the global Biosimilar Hormones Global market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Biosimilar Hormones Global industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Biosimilar Hormones Global market is being shaped by several major trends.
  • The size of the Biosimilar Hormones Global market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Biosimilar Hormones Global market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Biosimilar Hormones Global market as follows:
Global Biosimilar Hormones Global Market: By Product Type
  • Teriparatide Biosimilars
  • Follitropin Alfa Biosimilars
  • Insulin Biosimilars
  • Somatropin Biosimilars
  • Others

Global Biosimilar Hormones Global Market: By Application
  • Research & Biotechnology
  • Diagnostics
  • Biocatalysts
  • Therapeutics
  • Others

Global Biosimilar Hormones Global Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Biosimilar Hormones Global market.
  • Universities and students
  • Other companies in the Biosimilar Hormones Global market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Biosimilar Hormones Global market

Manufacturers and Segments

  • Teva Pharmaceutical
  • Gedeon Richter
  • Intas Pharmaceuticals
  • Biocon
  • Mylan
  • Sanofi
  • Sandoz (Novartis)
  • LG Life Sciences
  • Ferring Pharmaceuticals
  • GC Pharma
  • Teriparatide Biosimilars
  • Follitropin Alfa Biosimilars
  • Insulin Biosimilars
  • Somatropin Biosimilars
  • Others
  • Research & Biotechnology
  • Diagnostics
  • Biocatalysts
  • Therapeutics
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Biosimilar Hormones Global Market Snapshot
          2.1.1. Global Biosimilar Hormones Global Market By Teriparatide Biosimilars,2019
               2.1.1.1.
               2.1.1.2.Teriparatide Biosimilars
               2.1.1.3.Follitropin Alfa Biosimilars
               2.1.1.4.Insulin Biosimilars
               2.1.1.5.Somatropin Biosimilars
          2.1.2. Global Biosimilar Hormones Global Market By Research & Biotechnology,2019
               2.1.2.1.
               2.1.2.2.Research & Biotechnology
               2.1.2.3.Diagnostics
               2.1.2.4.Biocatalysts
               2.1.2.5.Therapeutics
          2.1.3. Global Biosimilar Hormones Global Market By End-use,2019
          2.1.4. Global Biosimilar Hormones Global Market By Geography,2019

3. Global Biosimilar Hormones Global Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Biosimilar Hormones Global Market Size (US$), By Teriparatide Biosimilars, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Teriparatide Biosimilars, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Teriparatide Biosimilars, 2020
     4.2. Global Biosimilar Hormones Global Market Size (US$), By Teriparatide Biosimilars, 2018 – 2028

5. Global Biosimilar Hormones Global Market Size (US$), By Research & Biotechnology, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Research & Biotechnology, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Research & Biotechnology, 2020
     5.2. Global Biosimilar Hormones Global Market Size (US$), By Research & Biotechnology, 2018 – 2028

6. Global Biosimilar Hormones Global Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Biosimilar Hormones Global Market Size (US$), By End-use, 2018 – 2028

7. Global Biosimilar Hormones Global Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Biosimilar Hormones Global Market Analysis, 2018 – 2028 
          7.2.1. North America Biosimilar Hormones Global Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Biosimilar Hormones Global Market Size (US$), By Teriparatide Biosimilars, 2018 – 2028
          7.2.3. North America Biosimilar Hormones Global Market Size (US$), By Research & Biotechnology, 2018 – 2028
          7.2.4. North America Biosimilar Hormones Global Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Biosimilar Hormones Global Market Analysis, 2018 – 2028 
          7.3.1.  Europe Biosimilar Hormones Global Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Biosimilar Hormones Global Market Size (US$), By Teriparatide Biosimilars, 2018 – 2028
          7.3.3. Europe Biosimilar Hormones Global Market Size (US$), By Research & Biotechnology, 2018 – 2028
          7.3.4. Europe Biosimilar Hormones Global Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Biosimilar Hormones Global Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Biosimilar Hormones Global Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Biosimilar Hormones Global Market Size (US$), By Teriparatide Biosimilars, 2018 – 2028
          7.4.3. Asia Pacific Biosimilar Hormones Global Market Size (US$), By Research & Biotechnology, 2018 – 2028
          7.4.4. Asia Pacific Biosimilar Hormones Global Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Biosimilar Hormones Global Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Biosimilar Hormones Global Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Biosimilar Hormones Global Market Size (US$), By Teriparatide Biosimilars, 2018 – 2028
          7.5.3. Latin America Biosimilar Hormones Global Market Size (US$), By Research & Biotechnology, 2018 – 2028
          7.5.4. Latin America Biosimilar Hormones Global Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Biosimilar Hormones Global Market Analysis, 2018 – 2028 
          7.6.1.  MEA Biosimilar Hormones Global Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Biosimilar Hormones Global Market Size (US$), By Teriparatide Biosimilars, 2018 – 2028
          7.6.3. MEA Biosimilar Hormones Global Market Size (US$), By Research & Biotechnology, 2018 – 2028
          7.6.4. MEA Biosimilar Hormones Global Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Biosimilar Hormones Global Providers
        8.4.1 Teva Pharmaceutical
                8.4.1.1 Business Description
                8.4.1.2 Teva Pharmaceutical Geographic Operations
                8.4.1.3 Teva Pharmaceutical Financial Information
                8.4.1.4 Teva Pharmaceutical Product Positions/Portfolio
                8.4.1.5 Teva Pharmaceutical Key Developments
        8.4.2 Gedeon Richter
                8.4.2.1 Business Description
                8.4.2.2 Gedeon Richter Geographic Operations
                8.4.2.3 Gedeon Richter Financial Information
                8.4.2.4 Gedeon Richter Product Positions/Portfolio
                8.4.2.5 Gedeon Richter Key Developments
        8.4.3 Intas Pharmaceuticals
                8.4.3.1 Business Description
                8.4.3.2 Intas Pharmaceuticals Geographic Operations
                8.4.3.3 Intas Pharmaceuticals Financial Information
                8.4.3.4 Intas Pharmaceuticals Product Positions/Portfolio
                8.4.3.5 Intas Pharmaceuticals Key Developments
        8.4.4 Biocon
                8.4.4.1 Business Description
                8.4.4.2 Biocon Geographic Operations
                8.4.4.3 Biocon Financial Information
                8.4.4.4 Biocon Product Positions/Portfolio
                8.4.4.5 Biocon Key Developments
        8.4.5 Mylan
                8.4.5.1 Business Description
                8.4.5.2 Mylan Geographic Operations
                8.4.5.3 Mylan Financial Information
                8.4.5.4 Mylan Product Positions/Portfolio
                8.4.5.5 Mylan Key Developments
        8.4.6 Sanofi
                8.4.6.1 Business Description
                8.4.6.2 Sanofi Geographic Operations
                8.4.6.3 Sanofi Financial Information
                8.4.6.4 Sanofi Product Positions/Portfolio
                8.4.6.5 Sanofi Key Developments
        8.4.7 Sandoz (Novartis)
                8.4.7.1 Business Description
                8.4.7.2 Sandoz (Novartis) Geographic Operations
                8.4.7.3 Sandoz (Novartis) Financial Information
                8.4.7.4 Sandoz (Novartis) Product Positions/Portfolio
                8.4.7.5 Sandoz (Novartis) Key Developments
        8.4.8 LG Life Sciences
                8.4.8.1 Business Description
                8.4.8.2 LG Life Sciences Geographic Operations
                8.4.8.3 LG Life Sciences Financial Information
                8.4.8.4 LG Life Sciences Product Positions/Portfolio
                8.4.8.5 LG Life Sciences Key Developments
        8.4.9 Ferring Pharmaceuticals
                8.4.9.1 Business Description
                8.4.9.2 Ferring Pharmaceuticals Geographic Operations
                8.4.9.3 Ferring Pharmaceuticals Financial Information
                8.4.9.4 Ferring Pharmaceuticals Product Positions/Portfolio
                8.4.9.5 Ferring Pharmaceuticals Key Developments
        8.4.10 GC Pharma
                8.4.10.1 Business Description
                8.4.10.2 GC Pharma Geographic Operations
                8.4.10.3 GC Pharma Financial Information
                8.4.10.4 GC Pharma Product Positions/Portfolio
                8.4.10.5 GC Pharma Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Biosimilar Hormones Global Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Biosimilar Hormones Global Market Revenue, By Teriparatide Biosimilars, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Biosimilar Hormones Global Market Revenue, By Research & Biotechnology, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Biosimilar Hormones Global Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Biosimilar Hormones Global Market Revenue, By Teriparatide Biosimilars, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Biosimilar Hormones Global Market Revenue, By Research & Biotechnology, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Biosimilar Hormones Global Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Biosimilar Hormones Global Market Revenue, By Teriparatide Biosimilars, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Biosimilar Hormones Global Market Revenue, By Research & Biotechnology, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Biosimilar Hormones Global Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Biosimilar Hormones Global Market Revenue, By Teriparatide Biosimilars, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Biosimilar Hormones Global Market Revenue, By Research & Biotechnology, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Biosimilar Hormones Global Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Biosimilar Hormones Global Market Revenue, By Teriparatide Biosimilars, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Biosimilar Hormones Global Market Revenue, By Research & Biotechnology, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Biosimilar Hormones Global Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Biosimilar Hormones Global: Market Segmentation 
FIG. 2 Global Biosimilar Hormones Global Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Biosimilar Hormones Global Market, By Teriparatide Biosimilars, 2019 (US$ Mn) 
FIG. 5 Global Biosimilar Hormones Global Market, By Research & Biotechnology, 2019 (US$ Mn) 
FIG. 6 Global Biosimilar Hormones Global Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Biosimilar Hormones Global Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Biosimilar Hormones Global Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Biosimilar Hormones Global Providers, 2019
FIG. 11 Global Biosimilar Hormones Global Market Revenue Contribution, By Teriparatide Biosimilars, 2019 & 2028 (Value %) 
FIG. 12 Global Biosimilar Hormones Global Market Revenue Contribution, By Research & Biotechnology, 2019 & 2028 (Value %) 
FIG. 13 Global Biosimilar Hormones Global Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Biosimilar Hormones Global Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Biosimilar Hormones Global Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Biosimilar Hormones Global Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Biosimilar Hormones Global Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Biosimilar Hormones Global Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Biosimilar Hormones Global market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Biosimilar Hormones Global Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Biosimilar Hormones Global Market Value, By Segment1, 2018 – 2028
TABLE  North America Biosimilar Hormones Global Market Value, By Segment2, 2018 – 2028
TABLE  North America Biosimilar Hormones Global Market Value, By Country, 2018 – 2028
TABLE  Europe Biosimilar Hormones Global Market Value, By Segment1, 2018 – 2028
TABLE  Europe Biosimilar Hormones Global Market Value, By Segment2, 2018 – 2028
TABLE  Europe Biosimilar Hormones Global Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Biosimilar Hormones Global Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Biosimilar Hormones Global Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Biosimilar Hormones Global Market Value, By Country, 2018 – 2028
TABLE  Latin America Biosimilar Hormones Global Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Biosimilar Hormones Global Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Biosimilar Hormones Global Market Value, By Country, 2018 – 2028
TABLE  MEA Biosimilar Hormones Global Market Value, By Segment1, 2018 – 2028
TABLE  MEA Biosimilar Hormones Global Market Value, By Segment2, 2018 – 2028
TABLE  MEA Biosimilar Hormones Global Market Value, By Country, 2018 – 2028
TABLE  Teva Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gedeon Richter: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Intas Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocon: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sandoz (Novartis): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  LG Life Sciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ferring Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GC Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Biosimilar Hormones Global Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Biosimilar Hormones Global Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Biosimilar Hormones Global Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Biosimilar Hormones Global Market, By Geography, 2019 (US$ Mn)
FIG.  Global Biosimilar Hormones Global Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Biosimilar Hormones Global Providers, 2016
FIG.  Global Biosimilar Hormones Global Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Teriparatide Biosimilars Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Follitropin Alfa Biosimilars Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Insulin Biosimilars Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Somatropin Biosimilars Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biosimilar Hormones Global Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Research & Biotechnology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biocatalysts Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Biosimilar Hormones Global Market Value, 2018 – 2028, (US$ Mn)